Table 2.
Samples from patients with a pathogenic germline ATM variant available for immunolabeling and targeted sequencing
| ID | Number of immunostained samples | Number of sequenced samples | ||||
|---|---|---|---|---|---|---|
| PanIN* | IPMN# | Invasive carcinoma | PanIN* | IPMN# | Invasive carcinoma | |
| P1 | 2 | - | 1 | 1 | - | - |
| P2 | 5 | 1 | - | 3 | 1 | 1 |
| P3 | 2 | 1 | - | - | - | 1 |
| P4 | 1 | - | 1 | - | - | 1 |
| P5 | 1 | - | 2 | - | - | 2 |
| P6 | 3 | - | 1 | 1 | - | 1 |
| P7 | 1 | - | 1 | - | - | 1 |
| P8 | - | 1 | 1 | - | - | - |
| P9 | 1 | - | 2 | 1 | - | 2 |
| P10 | - | - | 2 | - | - | 2 |
| P11 | - | - | 1 | - | - | 1 |
| P12 | 2 | - | 1 | 1 | - | - |
| P13 | 1 | - | 1 | 1 | - | - |
| P14 | - | - | 1 | - | - | 1 |
| P15 | 4 | - | 1 | 4 | - | 1 |
| P16 | - | - | 1 | - | - | 1 |
| P17 | 1 | 1 | - | - | - | |
| P18 | - | 1H | 1 | - | - | - |
| P19 | - | - | 1 | - | - | - |
| P20 | - | - | 1 | - | - | - |
| P21 | - | - | 1 | - | - | - |
| P22 | - | - | 1 | - | - | - |
| P23 | - | - | 1 | - | - | - |
| P24 | - | - | 1 | - | - | - |
| Total | 24 | 4 | 25 | 12 | 1 | 15 |
PanIN - Pancreatic intraepithelial neoplasm. IPMN - intraductal papillary mucinous neoplasm.
*
PanINs were all low-grade.
#
IPMNs were all low-grade except where indicated by H.